9-127824312-GCT-G
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_001114753.3(ENG):c.1124_1125delAG(p.Glu375AlafsTer20) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★). Synonymous variant affecting the same amino acid position (i.e. E375E) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001114753.3 frameshift
Scores
Clinical Significance
Conservation
Publications
- telangiectasia, hereditary hemorrhagic, type 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, ClinGen
- hereditary hemorrhagic telangiectasiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- juvenile polyposis syndromeInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001114753.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ENG | NM_001114753.3 | MANE Select | c.1124_1125delAG | p.Glu375AlafsTer20 | frameshift | Exon 8 of 15 | NP_001108225.1 | ||
| ENG | NM_000118.4 | c.1124_1125delAG | p.Glu375AlafsTer20 | frameshift | Exon 8 of 14 | NP_000109.1 | |||
| ENG | NM_001278138.2 | c.578_579delAG | p.Glu193AlafsTer20 | frameshift | Exon 8 of 15 | NP_001265067.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ENG | ENST00000373203.9 | TSL:1 MANE Select | c.1124_1125delAG | p.Glu375AlafsTer20 | frameshift | Exon 8 of 15 | ENSP00000362299.4 | ||
| ENG | ENST00000344849.5 | TSL:1 | c.1124_1125delAG | p.Glu375AlafsTer20 | frameshift | Exon 8 of 14 | ENSP00000341917.3 | ||
| ENG | ENST00000714047.1 | c.1124_1125delAG | p.Glu375AlafsTer20 | frameshift | Exon 8 of 15 | ENSP00000519338.1 |
Frequencies
GnomAD3 genomes Cov.: 30
GnomAD4 genome Cov.: 30
ClinVar
Submissions by phenotype
Telangiectasia, hereditary hemorrhagic, type 1 Pathogenic:1
This sequence change deletes 2 nucleotides from exon 8 of the ENG mRNA (c.1124_1125delAG), causing a frameshift at codon 375. This creates a premature translational stop signal (p.Glu375Alafs*20) and is expected to result in an absent or disrupted protein product. Loss-of-function variants in ENG are known to be pathogenic. This particular variant has been reported in the literature in individuals with hereditary hemorrhagic telangiectasia (PMID: 16752392, 23801935). For these reasons, this variant has been classified as Pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at